All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

States target pharmacy benefit managers with new laws to lower prescription drug costs

By

John Hanna

4h ago· 5 min readenNews

Summary

States across the U.S. are passing laws to regulate pharmacy benefit managers (PBMs) — middlemen that manage prescription drug coverage for health insurers — in an effort to lower medication costs for consumers. At least a dozen states enacted legislation this year limiting PBM compensation and setting minimum payments. CVS Health Corp., which operates a major PBM and also owns retail pharmacies, has spent millions fighting these regulations and filed a federal lawsuit arguing a new Tennessee law could force it to close all 136 of its pharmacies there by July 2028. The issue is politically charged ahead of midterm elections, with affordability remaining a key voter concern.

Source

bskyStates target pharmacy benefit managers with new laws to lower prescription drug costsapnews.com

Key quotes

· 3 pulled
Affordability is a key issue ahead of this year's midterm elections.
CVS Health Corp. operates a large pharmacy benefit manager and says a new Tennessee law could force CVS to close all 136 of its retail pharmacies there in July 2028.
Legislators in at least a dozen states passed laws this year to limit compensation to the companies, set minimum payments from the companies to pharmacies.
Snippet from the RSS feed
Legislators across the U.S. are trying to lower prescription costs by reining in big companies that handle drug coverage for health insurers. Their efforts have prompted one of the nation’s best-known brands to spend millions of dollars to hold off new re

You might also wanna read

Research Reveals Persistent Drug Pricing Distortions from PBM-Owned Pharmaceutical Companies

The article examines the persistent distortions in U.S. drug pricing, particularly focusing on vertically integrated pharmacy benefit manage

46brooklyn.com·7mo ago

Senators Investigate Pharmaceutical Companies' Direct-to-Consumer Telehealth Platforms for Steering Patients to High-Cost Drugs

U.S. senators are investigating direct-to-consumer (DTC) telehealth platforms operated by pharmaceutical companies like Eli Lilly and Pfizer

arstechnica.com·4mo ago

FDA Drug Regulator Accused of Targeting Former Business Associate's Pharmaceutical Company

The article discusses a scandal at the FDA involving a top drug regulator who allegedly used his position to target a former business associ

arstechnica.com·7mo ago

TrumpRx Website Launches for Direct-to-Consumer Prescription Drug Sales

The article announces the launch of TrumpRx, a government-run website where drug manufacturers will sell prescription medicines directly to

The Onion·8mo ago

U.S. restrictions on Chinese biotech could harm patients, argues editorial

The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec

economist.com·7d ago

CFPB Deregulation Under Trump Benefits Major Corporations Like Toyota, Walmart, and Apple

The article reports on how under President Donald Trump, acting CFPB head Russell Vought has aggressively deregulated the Consumer Financial

bloomberg.com·25d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.